This precision delivery system has 20mg of >ninety nine% pure Tirzepatide in a stabilized, sterile Resolution. As a “Dual Agonist,” Tirzepatide targets both equally GIP and GLP-one receptors, providing researchers a potent Device for investigating glucose homeostasis